Alain Fourquet

21.4k citations

374 papers · 14.0k indexed · 2 hit papers · h-index 62

Impact in

Cancer Research top 0.02%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Pathology and Forensic Medicine top 0.05%
- Breast Lesions and Carcinomas

Papers in

Cancer Research 267
- Breast Cancer Treatment Studies 254
- Cancer Genomics and Diagnostics 25
Pathology and Forensic Medicine 142
- Breast Lesions and Carcinomas 124

Co-authors: Youlia Kirova Bernard Asselain François Campana Harry Bartelink Laurence Collette Philip Poortmans H. Struikmans J.J. Jager
Journals: International Journal of Radiation Oncology*Biology*Physics (60 papers)Radiotherapy and Oncology (29 papers)European Journal of Cancer (24 papers)Journal of Clinical Oncology (15 papers)British Journal of Radiology (8 papers)
Partner nations: France Netherlands United States

In The Last Decade

Alain Fourquet

359 papers receiving 13.5k citations

Hit Papers

align trajectories log scale

Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial 2007 · 722 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Journal of Clinical Oncology
2001 New England Journal of Medicine

Peers

Countries citing papers authored by Alain Fourquet

Since Specialization

Citations

This map shows the geographic impact of Alain Fourquet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Fourquet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Fourquet more than expected).

Fields of papers citing papers by Alain Fourquet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Fourquet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Fourquet. The network helps show where Alain Fourquet may publish in the future.

Co-authors

The 25 scholars most cited alongside Alain Fourquet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alain Fourquet Line = papers co-authored together Alain Fourquet links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Young boost randomized phase III trial of high vs low boost radiation in young breast cancer patients: 10-year results European Journal of Cancer ·Sophie C.J. Bosma, Erik van Werkhoven, Harry Bartelink, Alain Fourquet, Coen Hurkmans, John H. Maduro, E. Rutgers, Luc J.E.E. Scheijmans, Dominic A.X. Schinagl, Marcel R. Stam, Marc J. van de Vijver, Helen Westenberg, Astrid N. Scholten, Philip Poortmans, Liesbeth Boersma	2024	4
2	Long-term efficacy and tolerance of a technique for postmastectomy electron beam radiation therapy of the unreconstructed chest wall and lymph node areas for non-metastatic breast cancers Cancer/Radiothérapie ·S. Souidi, Pierre Loap, F. Laki, M. Amessis, Alain Fourquet, Youlia Kirova	2023	1
3	Outcomes and toxicity of concurrent CDK4/6 inhibitor and locoregional radiotherapy for patients with de novo metastatic breast cancer International Journal of Cancer ·Arnaud Beddok, Victoire Mouren, Paul Cottu, F. Laki, Alain Fourquet, Youlia Kirova	2023	3
4	Aspects biologiques, précliniques et cliniques de l’association de radiothérapie et d’inhibiteur de CDK 4/6 Cancer/Radiothérapie ·Arnaud Beddok, Baptiste Porte, Paul Cottu, Alain Fourquet, Y. Kirova	2023	2
5	A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients Radiotherapy and Oncology ·Sophie C.J. Bosma, Marlous Hoogstraat, Erik van Werkhoven, Michiel de Maaker, Femke van der Leij, Paula H.M. Elkhuizen, Alain Fourquet, Philip Poortmans, Liesbeth Boersma, Harry Bartelink, Marc J. van de Vijver	2020	6
6	Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer American Journal of Clinical Oncology ·Zita Zolcsák, Delphine Loirat, Alain Fourquet, Youlia Kirova	2020	21
7	SP-0047: Between high-tech and biology: how to exploit protons, minibeams and flash irradiation to avoid toxicity? Radiotherapy and Oncology ·Alain Fourquet	2018	1
8	Caractérisation des rechutes locorégionales chez des patientes atteintes d’un cancer du sein traité par irradiation pariétale par électrons : expérience monocentrique de l’institut Curie Cancer/Radiothérapie ·Gokoulakrichenane Loganadane, Zhen Xi, N. Fournier‐Bidoz, Haoping Xu, N. Grellier, Louis Bazire, Alain Fourquet, Youlia Kirova	2018	2
9	Search for a Gene Expression Signature of Breast Cancer Local Recurrence in Young Women Clinical Cancer Research ·Nicolas Servant, Marc A. Bollet, Hans Halfwerk, Kevin Bleakley, Bas Kreike, Laurent Jacob, Daoud Sie, Ron Kerkhoven, Philippe Hupé, Rim Hadhri, Alain Fourquet, Harry Bartelink, Emmanuel Barillot, Brigitte Sigal‐Zafrani, Marc J. van de Vijver	2012	55
10	Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast Clinical Cancer Research ·Anne Vincent‐Salomon, Carlo Lucchesi, Nadège Gruel, Virginie Raynal, Gaëlle Pierron, Rémi Goudefroye, Fabien Reyal, François Radvanyi, Rémy Salmon, Jean Paul Thiery, Xavier Sastre‐Garau, Brigitte Sigal‐Zafrani, Alain Fourquet, Olivier Delattre, (unknown)	2008	114
11	The Impact of Boost Dose and Margins on the Local Recurrence Rate in Breast Conserving Therapy: Results From the EORTC Boost-No Boost Trial International Journal of Radiation OncologyBiologyPhysics ·Helen Jones, Ninja Antonini, L. Colette, Alain Fourquet, W.J. Hoogenraad, W. Van den Bogaert, J.J. Jager, P. Poortmans, H. Struikmans, Harry Bartelink	2007	6
12	Responses to concurrent radiotherapy and hormone-therapy and outcome for large breast cancers in post-menopausal women Radiotherapy and Oncology ·Marc A. Bollet, Youlia Kirova, Guillemette Antoni, J. Y. Pierga, Brigitte Sigal‐Zafrani, F. Laki, François Campana, R. Dendale, Rémy Salmon, Paul Cottu, Alain Fourquet	2007	18
13	Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ European Journal of Cancer ·Lawrence J. Solin, Alain Fourquet, Frank A. Vicini, Marie E. Taylor, Bruce G. Haffty, Eric A. Strom, Elaine S. Wai, Lori J. Pierce, Lawrence B. Marks, Harry Bartelink, François Campana, Marsha D. McNeese, Anuja Jhingran, Ivo A. Olivotto, Nina Bijker, Wei‐Ting Hwang	2005	21
14	Breast-conserving therapy for breast cancer Cancer/Radiothérapie ·Claude Nos, Virginie Doridot, Alain Fourquet, K.B. Clough, Brigitte Sigal‐Zafrani, J.S. Aucouturier	2004	2
15	[Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects]. PubMed ·Patricia de Crémoux, Véronique Dièras, Marie‐France Poupon, H Magdelénat, Brigitte Sigal‐Zafrani, Alain Fourquet, Jean‐Yves Pierga	2004	8
16	Minder lokale recidieven van borstkanker door extra lokale bestralingsdosis na mammasparende chirurgie: 5-jaarsresultaten van een klinische trial Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·H. Bartelink, P Poortmans, H. Struikmans, Jacques Borger, Josephus J. de Jager, W.J. Hoogenraad, W. Van den Bogaert, I. Barillot, Alain Fourquet, Laurence Collette, M. Piérart, J.C. Horiot	2002	1
17	Radiothérapie du cancer du sein. Problèmes techniques et nouvelles approches. Cancer/Radiothérapie ·Alain Fourquet, J. C. Rosenwald, F. Campana, G. Gaboriaud, R. Dendale, J. R. Vilcoq	2000	2
18	Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity. PubMed ·B Zafrani, Ariane Leroyer, Alain Fourquet, (unknown), (unknown), (unknown), (unknown)	1994	119
19	[Primary epidermoid carcinoma of the breast. Clinical, histopathologic and prognostic study of 14 patients]. PubMed ·Yi Jin, F. Campana, J. R. Vilcoq, Philippe Vielh, P Schlienger, G Mathieu, Alain Fourquet	1992	10
20	Cancer de la thyroïde. Analyse multidimensionnelle des facteurs pronostiques. Annales d Endocrinologie ·Alain Fourquet, B Asselain, J.-P. Joly	1983	9

About Alain Fourquet

Alain Fourquet is a scholar working on Cancer Research, Pathology and Forensic Medicine, Radiation, Oncology and Otorhinolaryngology, having authored 374 papers that have together received 14.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (254 papers), Breast Lesions and Carcinomas (124 papers), Advanced Radiotherapy Techniques (60 papers), Cancer Treatment and Pharmacology (40 papers), Breast Implant and Reconstruction (38 papers), HER2/EGFR in Cancer Research (33 papers), BRCA gene mutations in cancer (32 papers) and Cancer Genomics and Diagnostics (25 papers). The work is most often cited by research in Cancer Research (9.5k citations), Pathology and Forensic Medicine (5.6k citations), Radiation (2.2k citations), Oncology (5.5k citations) and Dermatology (921 citations). Alain Fourquet has collaborated with scholars based in France, Netherlands and United States. Frequent co-authors include Youlia Kirova, Bernard Asselain, François Campana, Harry Bartelink, Laurence Collette, Philip Poortmans, H. Struikmans, J.J. Jager, M. Piérart and W.J. Hoogenraad. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology, European Journal of Cancer, Journal of Clinical Oncology and British Journal of Radiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact